Literature DB >> 10088829

Canthaxanthine retinopathy.

A Espaillat, L P Aiello, P G Arrigg, R Villalobos, P M Silver, R W Cavicchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10088829     DOI： 10.1001/archopht.117.3.412

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  5 in total

Review 1.  Ocular adverse effects associated with systemic medications : recognition and management.

Authors:  Ricardo M Santaella; Frederick W Fraunfelder
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Crystalline Maculopathy Associated With High-Dose Lutein Supplementation.

Authors:  Rene Y Choi; Susan C Chortkoff; Aruna Gorusupudi; Paul S Bernstein
Journal:  JAMA Ophthalmol       Date:  2016-12-01       Impact factor: 7.389

3.  MACULAR PIGMENT DISTRIBUTION RESPONSES TO HIGH-DOSE ZEAXANTHIN SUPPLEMENTATION IN PATIENTS WITH MACULAR TELANGIECTASIA TYPE 2.

Authors:  Rene Y Choi; Aruna Gorusupudi; Kimberley Wegner; Mohsen Sharifzadeh; Werner Gellermann; Paul S Bernstein
Journal:  Retina       Date:  2017-12       Impact factor: 4.256

4.  Canthaxanthin retinopathy with visual loss: a case report and review.

Authors:  Robert A Beaulieu; Ronald E Warwar; Bruce M Buerk
Journal:  Case Rep Ophthalmol Med       Date:  2013-10-30

Review 5.  Interactions between canthaxanthin and lipid membranes--possible mechanisms of canthaxanthin toxicity.

Authors:  Agnieszka Sujak
Journal:  Cell Mol Biol Lett       Date:  2009-02-12       Impact factor: 5.787
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.